Getinge (GETI B.ST) Akcie Kurz
Getinge Kurz
Tržby rostly o 5,3 % ročně za posledních 19 let na 34,97 Mld. SEK. Zisk na akcii rostl o 3,1 % ročně za posledních 19 let. čistá marže společnosti Getinge je nyní 6,5 %, dolů z 11,0 % před několika lety. Getinge aktuálně nabízí dividendový výnos kolem 1,72 %. Výplatní poměr je kolem 55 % zisku. Dividenda rostla o 4,7 % ročně za posledních 19 let. Medián cílové ceny analytiků je 231,03 SEK, tedy pod aktuální cenu o 13,7 %. Z 14 analytiků jich 8 doporučuje nákup — celkový konsenzus je Koupit.
Cena akcie Getinge
Tato data přes Eulerpool API
100 000 požadavků/měs. zdarma · bez karty
Obchodní model Getinge a analýza akcií
Nejčastější otázky týkající se akcie Getinge
Getinge AB is a global medical technology company that specializes in providing solutions for hospitals and healthcare organizations. The business model of Getinge AB revolves around offering innovative products, systems, and services within areas such as surgical workflows, patient care, and infection control. They strive to improve patient outcomes and enable healthcare professionals to deliver efficient and safe care. With a focus on providing high-quality medical equipment and integrated solutions, Getinge AB aims to enhance the overall healthcare experience.
Getinge AB is primarily active in the healthcare industry.
The main competitors of Getinge AB in the market include leading medical technology companies such as Medtronic, Johnson & Johnson, and Siemens Healthineers. These companies also provide a wide range of innovative medical devices and solutions, competing with Getinge AB in areas such as surgical equipment, patient handling systems, and infection control products. Getinge AB, as a global provider of medical technology, faces intense competition in its quest to deliver advanced healthcare solutions to customers worldwide.
Getinge AB, a renowned Swedish company, has a rich history and a strong background in the healthcare industry. Established in 1904, Getinge has evolved into a global leader in medical technology, providing innovative solutions for infection control and surgical workflows. With a primary focus on improving patient outcomes and enhancing healthcare efficiency, Getinge offers a wide range of products and services, including advanced medical equipment, such as surgical tables, anesthesia systems, and sterilization equipment. Over the years, Getinge has expanded its operations internationally, becoming a trusted partner for healthcare institutions worldwide. Through continuous innovation and dedication to healthcare excellence, Getinge AB has firmly established itself as a leading player in the global medical technology market.
Getinge AB has achieved several significant milestones throughout its history. One major accomplishment was the acquisition of Maquet in 2000, which expanded the company's portfolio and global reach. In 2006, Getinge AB successfully listed its shares on the Stockholm Stock Exchange, strengthening its position in the market. The company has also made substantial progress in research and development, introducing innovative medical technology solutions for healthcare professionals worldwide. Additionally, Getinge AB has focused on sustainability initiatives, committing to reducing its carbon footprint and promoting environmentally friendly practices. These milestones demonstrate Getinge AB's commitment to growth, innovation, and sustainability in the healthcare industry.
Getinge AB, a renowned global medical technology company based in Sweden, operates in multiple countries and regions worldwide. With a strong international presence, Getinge AB extends its operations across various continents, including Europe, Asia, North America, and Latin America. The company establishes its footprint in countries such as Sweden, Germany, France, the United States, China, Brazil, and many more. Through its extensive network and subsidiaries, Getinge AB serves customers across the globe, contributing to the advancement of healthcare and improving patient outcomes.
Getinge AB is committed to upholding certain values and corporate philosophy. The company believes in promoting patient safety and enhancing healthcare outcomes. They prioritize quality in their products and services, ensuring efficient and reliable medical solutions. Getinge AB strives for sustainability by minimizing the environmental impact of their operations and products. They value transparency, integrity, and accountability in their business practices. Getinge AB consistently focuses on innovation and advancement in the healthcare industry, aiming to improve patients' lives worldwide. With their dedication to their mission and values, Getinge AB continues to be a trusted and influential player in the medical technology sector.
Analytici aktuálně stanovují průměrnou cílovou cenu 238,81 SEK pro akcii Getinge (medián: 231,03 SEK), tedy -10,6 % vůči poslední ceně. Konsensus vychází z 14 hodnocení analytiků.
14 analytiků aktuálně hodnotí akcii Getinge: 8 doporučuje koupit, 5 držet a 1 prodat. Pro rok 2026 analytici očekávají u Getinge tržby 35,26 Mld. SEK a zisk na akcii 12,89 SEK.
Při aktuálním kurzu se akcie Getinge obchoduje za 24,08 EUR (267,70 SEK).
Akcie Getinge (GETI B.ST) je kótována na 9 burzách, mimo jiné: London (0GZV.L), SIX (Zürich) (GETIB.SW), Frankfurt (GTN.F), München (GTN.MU), Düsseldorf (GTN.DU), Stockholm (GETI B.ST).
Getinge AB is a Swedish company specializing in the manufacturing of medical devices and solutions. The company operates in three main areas: Acute Care Therapies, Life Science, and Surgical Workflows. Getinge offers products and services to improve patient care and enhance the efficiency and profitability of hospitals and medical facilities. They provide solutions for critical care situations, infection prevention and control, as well as for the life sciences, pharmaceutical, and food industries. Getinge also offers products and solutions for surgical workflows, including cleaning, disinfection, sterilization, and training services. The company follows a value-based healthcare model, aiming to provide value to customers by ensuring optimal patient treatment and economic responsibility. With a focus on continuous innovation, Getinge strives to meet the evolving needs of its customers as a global leader in the medical technology industry.
Tržby očekávané za Getinge činí 35,26 Mld. SEK. Tato hodnota je založena na aktuálních finančních údajích a odráží výkonnost společnosti.
Zisk očekávané za Getinge činí 3,51 Mld. SEK. Čistý zisk odráží ziskovost společnosti po odečtení všech nákladů.
Poměr ceny k zisku (P/E) Getinge je aktuálně 20,77. Poměr P/E porovnává aktuální cenu akcie se ziskem na akcii a pomáhá investorům posoudit ocenění akcie Getinge.
Poměr ceny k tržbám (P/S) Getinge je aktuálně 2,07. Poměr P/S porovnává tržní kapitalizaci s ročními tržbami a slouží jako metrika ocenění akcie Getinge.
Score kvality pro Getinge je 4/10.
ISIN Getinge je SE0000202624. ISIN (International Securities Identification Number) je celosvětově jedinečný identifikátor cenných papírů.
WKN Getinge je 889714. WKN (Wertpapierkennnummer) je šestimístný německý identifikační kód cenného papíru.
Ticker Getinge je GETI B.ST. Symbol tickeru se používá k obchodování akcií Getinge na burze.
Getinge akcie
Getinge Peer Group
Getinge Ticker
Getinge FIGI
Všechny fundamentální údaje o Getinge v podrobné analýze
Naše analýzy akcií společnosti Getinge zahrnují důležité finanční ukazatele jako obrat, zisk, P/E poměr, P/S poměr, EBIT, stejně jako informace o dividendách. Dále zkoumáme aspekty jako akcie, tržní kapitalizaci, dluhy, vlastní kapitál a závazky společnosti Getinge. Pokud hledáte podrobnější informace o těchto tématech, nabízíme vám na našich podstránkách rozsáhlé analýzy: